NuCana plc - American Depositary Share (NCNA) Social Stream



NuCana plc - American Depositary Share (NCNA): $1.21

-0.22 (-15.38%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NCNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 386

in industry

NUCANA PLC (NCNA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NCNA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-23 6 $22 $10 $18 $1.28 1306.25%
2021-11-24 6 $22 $9 $17.75 $1.28 1286.72%
2022-03-14 5 $22 $5 $14.25 $1.28 1013.28%
2022-06-05 5 $21 $5 $10.25 $1.28 700.78%
2022-08-17 5 $21 $5 $10.666 $1.28 733.28%
2022-08-22 4 $21 $5 $10.666 $1.28 733.28%
2022-11-16 5 $6 $3 $4.666 $1.28 264.53%
2022-11-20 5 $6 $3 $4.333 $1.28 238.52%
2023-03-12 4 $6 $3 $4.333 $1.28 238.52%

The Trend in the Analyst Price Target


NCNA's average price target has moved down $13.67 over the prior 16 months.

Over the past 48 weeks, NCNA's average upside potential has been 778.65%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-13 5 21 5 10.250 1.060 866.98%
2022-05-01 5 21 5 10.250 0.703 1358.04%
2022-06-07 5 21 5 10.666 0.618 1625.89%
2022-09-22 5 6 3 4.666 1.140 309.3%
2022-11-16 5 6 3 4.666 1.060 340.19%

NCNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


NCNA's average broker recommendation rating improved by 0.5 over the prior 30 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NCNA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, NUCANA PLC's upside potential (average analyst target price relative to current price) is higher than 928.53% of them.
  • In the context of all US stocks, NUCANA PLC's average analyst price target is greater than 126.49% of them.
  • NCNA has a lower variance in analysts' estimates than -727.92% of all US stocks.
  • NUCANA PLC's number of analysts covering the stock is greater than 300.94% of Healthcare stocks.

Stocks similar to NUCANA PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KALA, ATHE, and VRNA.

Make investment decisions regarding NCNA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8308 seconds.